SPRR3 and myocardial infarction: TTC staining demonstrated that CR-SPRC and SPRC significantly reduced the infarct size in the left ventricle compared with the MI group (18.5±4.8% and 21.8±2.1% compared with 35.8±4.4%; P< 0.01, respectively) (Figure 1).